You have read all your free articles, to continue reading subscribe to read the rest of this content.
Gedea Biotech has been granted a patent by the United States Patent and Trademark Office for the treatment of fungal infections by the company’s compound glucono-δ-lactone (GDL). The patent can be kept in force until 2037, states the company in a press release. “The US market for treatmenAlready a subscriber…
Ilya Pharma has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,696,974 to the company. The patent includes broad claims that cover a plasmid capable of expressing the protein CXCL12 in lactic acid bacteria, transformed lactic acid bacterial straAlready a subscriber Login You…
The European Patent Office has informed Diamyd Medical that the company’s patent application regarding prevention and treatment of autoimmune diabetes in individuals carrying the HLA DR3-DQ2 gene will be granted. The patent is valid until 2035 and provides central protection in Europe for the tAlready a subscriber Login You have…
Idogen announces that the European Patent Office will formally grant a patent application, covering the company’s tolerogenic vaccine technology. The EPO approval strengthens the company’s patent portfolio for the vaccine technology. A patent in the same patent family has already been grantedAlready a subscriber Login You have read all your…
